NO752423L - - Google Patents

Info

Publication number
NO752423L
NO752423L NO752423A NO752423A NO752423L NO 752423 L NO752423 L NO 752423L NO 752423 A NO752423 A NO 752423A NO 752423 A NO752423 A NO 752423A NO 752423 L NO752423 L NO 752423L
Authority
NO
Norway
Application number
NO752423A
Other languages
Norwegian (no)
Other versions
NO143224B (no
NO143224C (no
Inventor
A Soeder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO752423L publication Critical patent/NO752423L/no
Publication of NO143224B publication Critical patent/NO143224B/no
Publication of NO143224C publication Critical patent/NO143224C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO752423A 1974-07-05 1975-07-04 Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner NO143224C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (3)

Publication Number Publication Date
NO752423L true NO752423L (cg-RX-API-DMAC7.html) 1976-01-06
NO143224B NO143224B (no) 1980-09-22
NO143224C NO143224C (no) 1981-01-02

Family

ID=27048497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752423A NO143224C (no) 1974-07-05 1975-07-04 Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner

Country Status (14)

Country Link
JP (1) JPS5250800B2 (cg-RX-API-DMAC7.html)
AR (1) AR210330A1 (cg-RX-API-DMAC7.html)
AT (1) AT339917B (cg-RX-API-DMAC7.html)
CA (1) CA1062710A (cg-RX-API-DMAC7.html)
CH (2) CH622519A5 (cg-RX-API-DMAC7.html)
DK (1) DK140214B (cg-RX-API-DMAC7.html)
ES (1) ES439141A1 (cg-RX-API-DMAC7.html)
FI (1) FI59249C (cg-RX-API-DMAC7.html)
FR (1) FR2277089A1 (cg-RX-API-DMAC7.html)
GB (1) GB1500039A (cg-RX-API-DMAC7.html)
LU (1) LU72897A1 (cg-RX-API-DMAC7.html)
NL (1) NL166476C (cg-RX-API-DMAC7.html)
NO (1) NO143224C (cg-RX-API-DMAC7.html)
SE (2) SE420097B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Also Published As

Publication number Publication date
FI59249C (fi) 1981-07-10
JPS5250800B2 (cg-RX-API-DMAC7.html) 1977-12-27
FI751958A7 (cg-RX-API-DMAC7.html) 1976-01-06
JPS5134194A (cg-RX-API-DMAC7.html) 1976-03-23
ES439141A1 (es) 1977-02-16
NL7507976A (nl) 1976-01-07
DK301775A (cg-RX-API-DMAC7.html) 1976-01-06
DK140214C (cg-RX-API-DMAC7.html) 1979-12-03
NL166476B (nl) 1981-03-16
ATA517275A (de) 1977-03-15
AR210330A1 (es) 1977-07-29
AT339917B (de) 1977-11-10
SE420097B (sv) 1981-09-14
SE427183B (sv) 1983-03-14
CA1062710A (en) 1979-09-18
NL166476C (nl) 1981-08-17
CH622519A5 (en) 1981-04-15
AU8275575A (en) 1977-01-06
SE7507726L (sv) 1976-01-07
FR2277089B1 (cg-RX-API-DMAC7.html) 1978-03-17
CH622018A5 (en) 1981-03-13
LU72897A1 (cg-RX-API-DMAC7.html) 1976-05-31
NO143224B (no) 1980-09-22
DK140214B (da) 1979-07-09
SE7807853L (sv) 1978-07-14
FI59249B (fi) 1981-03-31
FR2277089A1 (fr) 1976-01-30
NO143224C (no) 1981-01-02
GB1500039A (en) 1978-02-08

Similar Documents

Publication Publication Date Title
DK82775A (cg-RX-API-DMAC7.html)
FR2277089B1 (cg-RX-API-DMAC7.html)
CS171582B1 (cg-RX-API-DMAC7.html)
CS166545B1 (cg-RX-API-DMAC7.html)
CS164741B1 (cg-RX-API-DMAC7.html)
CS168450B1 (cg-RX-API-DMAC7.html)
CS169608B1 (cg-RX-API-DMAC7.html)
CH608023A5 (cg-RX-API-DMAC7.html)
CH576898A5 (cg-RX-API-DMAC7.html)
CH580750A5 (cg-RX-API-DMAC7.html)
CH589327A5 (cg-RX-API-DMAC7.html)
CH614956A5 (cg-RX-API-DMAC7.html)
CH580837B5 (cg-RX-API-DMAC7.html)
CH590125A5 (cg-RX-API-DMAC7.html)
CH604191A5 (cg-RX-API-DMAC7.html)
CH564966A5 (cg-RX-API-DMAC7.html)
CH577203B5 (cg-RX-API-DMAC7.html)
CH600399A5 (cg-RX-API-DMAC7.html)
BG20446A1 (cg-RX-API-DMAC7.html)
CH586891A5 (cg-RX-API-DMAC7.html)
CH574593A5 (cg-RX-API-DMAC7.html)
CH602690A5 (cg-RX-API-DMAC7.html)
CH585950A5 (cg-RX-API-DMAC7.html)
CH575486A5 (cg-RX-API-DMAC7.html)
CH595900A5 (cg-RX-API-DMAC7.html)